Literature DB >> 25976189

Mesenterial involvement of Mycobacterium genavense infection: hard to find, hard to treat.

Nasstasja Wassilew1, Laura Ciaffi1, Alexandra Calmy1.   

Abstract

Mycobacterium genavense is a rare pathogen affecting severely immunosuppressed patients. We report the case of persistent relapsing M. genavense infection in a 48-year-old African man with a positive diagnosis of HIV infection. Despite being under effective antiretroviral therapy with partial immune reconstitution, he developed irreversible long-term abdominal complications, possibly due to persistent M. genavense infection and sustained inflammation. Case management consists of individual risk assessment, close follow-up and personalised treatment strategies concerning the duration of antimycobacterial therapy and early application of steroids. Patients with profound immunosuppression, a high viral load at HIV diagnosis and a high burden of M. genavense, appear to be at higher risk. The pathogenicity of this complication is not well known and its optimal management has still to be determined. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 25976189      PMCID: PMC4434391          DOI: 10.1136/bcr-2014-208241

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  24 in total

Review 1.  Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy.

Authors:  Samuel A Shelburne; Richard J Hamill; Maria C Rodriguez-Barradas; Stephen B Greenberg; Robert L Atmar; Daniel W Musher; Joseph C Gathe; Fehmida Visnegarwala; Barbara W Trautner
Journal:  Medicine (Baltimore)       Date:  2002-05       Impact factor: 1.889

2.  Mycobacterium genavense in the Netherlands: an opportunistic pathogen in HIV and non-HIV immunocompromised patients. An observational study in 14 cases.

Authors:  W Hoefsloot; J van Ingen; E J G Peters; C Magis-Escurra; P N R Dekhuijzen; M J Boeree; D van Soolingen
Journal:  Clin Microbiol Infect       Date:  2012-03-22       Impact factor: 8.067

3.  Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy.

Authors:  M A French; N Lenzo; M John; S A Mallal; E J McKinnon; I R James; P Price; J P Flexman; M L Tay-Kearney
Journal:  HIV Med       Date:  2000-03       Impact factor: 3.180

4.  Mycobacterium genavense infections: a retrospective multicenter study in France, 1996-2007.

Authors:  Pierre Charles; Olivier Lortholary; Agnès Dechartres; Fahranoosh Doustdar; Jean Paul Viard; Marc Lecuit; Maria Cristina Gutierrez
Journal:  Medicine (Baltimore)       Date:  2011-07       Impact factor: 1.889

5.  Recurrence of Mycobacterium avium infection in patients receiving highly active antiretroviral therapy and antimycobacterial agents.

Authors:  S K Cinti; D R Kaul; P E Sax; L R Crane; P H Kazanjian
Journal:  Clin Infect Dis       Date:  2000-03       Impact factor: 9.079

6.  Sclerosing mesenteritis: clinical features, treatment, and outcome in ninety-two patients.

Authors:  Salma Akram; Darrell S Pardi; John A Schaffner; Thomas C Smyrk
Journal:  Clin Gastroenterol Hepatol       Date:  2007-05       Impact factor: 11.382

7.  Disseminated "Mycobacterium genavense" infection in patients with AIDS.

Authors:  E C Böttger; A Teske; P Kirschner; S Bost; H R Chang; V Beer; B Hirschel
Journal:  Lancet       Date:  1992-07-11       Impact factor: 79.321

8.  [Immune reconstitution inflammatory syndrome (IRIS) of the small bowel in an immunocompromised patient suffering from systemic lupus erythematosus and non-tuberculous mycobacteriosis].

Authors:  S Daum; V Moos; C Loddenkemper; C Schürmann; E Märker-Hermann; H Stein; M Zeitz; T Schneider
Journal:  Z Rheumatol       Date:  2008-07       Impact factor: 1.372

9.  Localized osteomyelitis due to Mycobacterium avium complex in patients with Human Immunodeficiency Virus receiving highly active antiretroviral therapy.

Authors:  Judith A Aberg; Peter V Chin-Hong; Allen McCutchan; Susan L Koletar; Judith S Currier
Journal:  Clin Infect Dis       Date:  2002-06-04       Impact factor: 9.079

10.  Early diagnosis of disseminated Mycobacterium genavense infection.

Authors:  Victoire de Lastours; Romain Guillemain; Jean-Luc Mainardi; Agnès Aubert; Patrick Chevalier; Agnès Lefort; Isabelle Podglajen
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

View more
  1 in total

1.  Mycobacterium genavense invading the bone marrow in a HIV-positive patient.

Authors:  Christianne Bourlon; Cesar Vargas-Serafín; Xavier López-Karpovitch
Journal:  Clin Case Rep       Date:  2017-04-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.